- Acute migraine headache:
- Adults & >12yrs: PO 6.25mg-12.5mg *1
- 25mg/24h
- May repeat dose *1 after 2 hours
- Tablet:
- 6.25mg
- 12.5mg
None remarkable
Selective serotonin receptor agonists
It activates vascular serotonin 5-HT1 receptors, producing vasoconstriction and reduces inflammation associated with antidronic neuronal transmission associated with relief of migraine
- Somnolence
- Dizziness
- Nausea
- Headache
- Vomiting
- Chest pain or discomfort
- Jaw pain or discomfort
- Neck pain or discomfort
- Hypersensitivity to drug or ingredient
- Ischemic heart disease
- Coronary vasospasm
- Uncontrolled hypertension
- Cerebrovascular disease
- Peripheral Vascular Disease
- Ischemic bowel disease
- Basilar & hemiplegic migraine
- Dihydroergotamine
- Eletriptan
- Ergotamine
- Frovatriptan
- Methylergonovine
- Naratriptan
- Rizatriptan
- Sumatriptan
- Zolmitriptan
Drug Status
Availability | Prescription only |
Pregnancy | Category C |
Breastfeeding | Weigh risk vs benefit |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Almotan | 6.25mg | Tablet | 6’s | MSN Labs | Simba Pharma |
Almotan | 12.5mg | Tablet | 6’s | MSN Labs | Simba Pharma |